Na Zhang | Pharmaceutical Science | Best Researcher Award

Prof. Na Zhang | Pharmaceutical Science | Best Researcher Award

Shandong university, China.

Dr. Na Zhang is a distinguished professor at the Institute of Pharmaceutics, Shandong University, China. She earned her Ph.D. in Pharmaceutics from China Pharmaceutical University in July 2004, following her Master’s and Bachelor’s degrees in Pharmacy from Shandong Medical University. Over her extensive career, Dr. Zhang has made significant contributions to the field of pharmaceutics, focusing on innovative drug delivery systems and cancer therapies. With over two decades of academic and research experience, she has established herself as a leader in her field, exemplified by her role as Associate Dean of the School of Pharmaceutical Science. Dr. Zhang’s research has garnered international recognition through numerous publications in high-impact journals, collaborative projects, and successful funding grants. She is dedicated to advancing pharmaceutical education while actively engaging in cutting-edge research that addresses critical healthcare challenges.

Professional Profile

Education

Dr. Na Zhang completed her Ph.D. in Pharmaceutics at the School of Pharmacy, China Pharmaceutical University, in July 2004. Prior to that, she obtained her Master’s degree in Pharmacy in July 1995 from Shandong Medical University, and her Bachelor’s degree in Pharmacy from the same institution in July 1992. Her educational journey has laid a solid foundation for her expertise in pharmaceutics, equipping her with the knowledge and skills to excel in both research and academic settings. Throughout her studies, Dr. Zhang has consistently demonstrated a commitment to academic excellence and innovation, which is evident in her subsequent professional achievements. Her comprehensive educational background enables her to contribute significantly to the fields of drug delivery systems and cancer immunotherapy, fostering the development of advanced pharmaceutical solutions that address pressing health issues.

Professional Experience

Dr. Na Zhang has a robust professional background spanning over two decades in academia and research. Since January 2013, she has served as a professor and Associate Dean at the School of Pharmaceutical Science, Shandong University. Prior to this, she held various positions, including Associate Professor and lecturer at Shandong University and a postdoctoral fellowship at the University of Kansas. Dr. Zhang’s career trajectory illustrates her dedication to the advancement of pharmaceutical sciences through teaching, research, and leadership. Her roles have involved mentoring students and researchers, developing curricula, and contributing to institutional governance. Dr. Zhang’s extensive experience in academia enables her to bridge the gap between scientific research and education, ensuring that her students are well-prepared for future challenges in the pharmaceutical industry.

Research Interests

Dr. Na Zhang’s research interests encompass a wide range of areas within pharmaceutics, particularly focusing on innovative drug delivery systems. She specializes in nano-drug delivery systems, exploring stimuli-responsive carriers for targeted therapy, and cancer immunotherapy. Her work on small molecule-based nanodrugs aims to enhance the efficacy and safety of cancer treatments, addressing critical challenges in current therapeutic approaches. Additionally, she engages in pre-clinical biopharmaceutical evaluation to assess the pharmacokinetics and dynamics of her developed formulations. By combining her expertise in nanotechnology and pharmaceutical sciences, Dr. Zhang seeks to contribute significantly to the field, improving treatment outcomes for patients with cancer and other complex diseases.

Research Skills

Dr. Na Zhang possesses a diverse array of research skills that enhance her effectiveness as a scientist and educator. Her expertise includes the design and development of nano-drug delivery systems, with a particular focus on creating stimuli-responsive carriers. She is proficient in pre-clinical biopharmaceutical evaluation, which involves assessing the pharmacological and therapeutic properties of new drug formulations. Additionally, Dr. Zhang has extensive experience in experimental design, data analysis, and scientific writing, which are essential for conducting high-quality research and publishing in reputable journals. Her collaborative approach fosters interdisciplinary partnerships, enhancing her research’s impact and relevance. Furthermore, her leadership in academic settings enables her to mentor aspiring researchers, sharing her knowledge and skills to cultivate the next generation of pharmaceutical scientists.

Awards and Honors

Dr. Na Zhang’s outstanding contributions to pharmaceutical sciences have earned her numerous awards and honors throughout her career. She has been recognized for her innovative research in nano-drug delivery and cancer immunotherapy, reflecting her commitment to advancing healthcare solutions. Her research has garnered prestigious funding from national bodies, highlighting the significance of her work in the field. Furthermore, Dr. Zhang has received accolades for her excellence in teaching and mentoring, demonstrating her dedication to fostering academic growth among her students. As a published author in high-impact journals, she has received recognition from peers and the broader scientific community for her contributions to advancing pharmaceutical knowledge. Her achievements underscore her influence as a researcher and educator in the pharmaceutical sciences.

Conclusion:

Dr. Na Zhang stands out as an exemplary candidate for the Best Researcher Award due to her significant contributions to pharmaceutical sciences, particularly in nano-drug delivery and cancer immunotherapy. Her impressive publication record, successful acquisition of research funding, and commitment to education reflect her dedication and impact in the field. By addressing the areas for improvement, Dr. Zhang can further enhance her influence and leadership within the global research community. Thus, she is highly deserving of this recognition.

Publications Top Notes

  1. Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours
    • Authors: Liu, J., Zhao, H., Gao, T., Zhang, N., Liu, Y.
    • Year: 2024
  2. Self-delivery photothermal-boosted-nanobike multi-overcoming immune escape by photothermal/chemical/immune synergistic therapy against HCC
    • Authors: Yang, H., Mu, W., Yuan, S., Liu, Y., Zhang, N.
    • Year: 2024
  3. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
    • Authors: Liu, J., Liu, J., Mu, W., Liu, Y., Zhang, N.
    • Year: 2024
    • Citations: 1
  4. In Situ Hydrogel Modulates cDC1-Based Antigen Presentation and Cancer Stemness to Enhance Cancer Vaccine Efficiency
    • Authors: Gao, T., Yuan, S., Liang, S., Zhang, N., Liu, Y.
    • Year: 2024
  5. Nano-Regulator Inhibits Tumor Immune Escape via the “Two-Way Regulation” Epigenetic Therapy Strategy
    • Authors: Liang, S., Liu, M., Mu, W., Jiang, D., Zhang, N.
    • Year: 2024
    • Citations: 3
  6. Cell Membrane Biomimetic Nano-Delivery Systems for Cancer Therapy
    • Authors: Xia, Z., Mu, W., Yuan, S., Liu, Y., Zhang, N.
    • Year: 2023
    • Citations: 2
  7. Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy
    • Authors: Xia, Y., Fu, S., Ma, Q., Liu, Y., Zhang, N.
    • Year: 2023
    • Citations: 30
  8. Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling
    • Authors: Fu, S., Chang, L., Liu, S., Liu, Y., Zhang, N.
    • Year: 2023
    • Citations: 32
  9. Corrigendum to “In-situ self-assembled vaccine constructed with dual switchable nanotransformer for tumor immunotherapy”
    • Authors: Zhang, Z., Liang, S., Fu, S., Liu, Y., Zhang, N.
    • Year: 2023
  10. Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
  • Authors: Gao, T., Sang, X., Huang, X., Liu, Y., Zhang, N.
  • Year: 2023
  • Citations: 3

 

 

 

Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Assist Prof Dr. Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Assistant Professor, EDA, Egypt

With a solid foundation in pharmacy, including a Bachelor’s, Master’s, and PhD from Cairo University, and a position as Associate Professor, this individual demonstrates exceptional expertise. Their diverse professional experience spans quality control, management, and academic roles, showcasing their leadership and practical knowledge in the pharmaceutical field. Their prolific research output includes numerous publications on advanced drug delivery systems and nanotechnology, reflecting significant contributions to pharmaceutical sciences. Active participation in various training courses, workshops, and international conferences highlights their commitment to continuous professional development. Additionally, their multilingual skills enhance their ability to collaborate in diverse settings. Overall, their comprehensive background in education, research, and professional development, combined with their active engagement in the scientific community, makes them a highly suitable candidate for the Best Researcher Award.

Education

The candidate has a robust educational background that serves as the foundation of their expertise in the field of pharmaceutical sciences. They earned a Bachelor of Pharmacy degree from Cairo University in 1996, graduating with honors, which set the stage for their academic and professional journey. Their pursuit of advanced knowledge led them to complete a Master’s degree in Pharmaceutics in 2007 and later a PhD in 2011, both from the same esteemed institution. This rigorous academic training has equipped them with in-depth knowledge of pharmaceutics, drug formulation, and pharmaceutical analysis. In 2019, they further solidified their academic credentials by attaining the position of Associate Professor, demonstrating their commitment to education, research, and mentorship. Their continuous academic progression reflects a strong commitment to excellence and a desire to contribute significantly to the pharmaceutical sciences, positioning them as a thought leader in their field and a prime candidate for the Best Researcher Award.

Profesional Experience

The candidate has an extensive professional background in the pharmaceutical sector, beginning their career as a QC analyst for raw materials at NODCAR from 1996 to 1999. They then transitioned to academia as a teaching assistant at the Faculty of Pharmacy, October University, in 1999. Between 2000 and 2012, they worked as a QC analyst specializing in physical properties before moving into management roles, including quality manager and deputy lab manager. From 2016 to 2021, they served as a technical manager, demonstrating their expertise in overseeing laboratory operations and maintaining quality standards. Their role expanded further as they joined several committees, contributing to updating pharmaceutical guidelines and developing the Egyptian pharmacopeia. In 2021, they became the lab manager of the physicochemical lab at the Egyptian Drug Authority (EDA), where they continue to lead and innovate in quality control and research.

Research Skill

The candidate possesses exceptional research skills, demonstrated through a prolific publication record in high-impact journals and extensive experience in developing innovative pharmaceutical formulations. They have expertise in designing and conducting complex experimental studies, including the use of advanced methodologies like Box–Behnken design for optimization and in vivo evaluations. Their research work spans various domains, including nanotechnology, ocular drug delivery, and gastroretentive systems, showcasing versatility and a strong ability to adapt to emerging scientific trends. Additionally, their role in supervising master’s and PhD theses highlights their leadership in guiding future researchers. The candidate is also well-versed in utilizing statistical analysis tools and quality-by-design approaches, which are critical for ensuring the rigor and reliability of research findings. Their ability to translate research into practical applications, coupled with active participation in committees that shape pharmaceutical guidelines, underscores a profound impact on both academic and industry standards in the pharmaceutical sciences.

Awards And Recoginition

The individual has received multiple accolades throughout their career, reflecting their outstanding contributions to the field of pharmaceutical sciences. Their expertise in pharmaceutics and dedication to research have been recognized by esteemed institutions and professional bodies. Notably, they have been honored for their innovative work in drug delivery systems and quality management, which have had a significant impact on the pharmaceutical industry. They have been a valuable member of committees responsible for updating pharmaceutical guidelines and establishing national standards, further highlighting their influence and leadership in the field. Additionally, their research publications in renowned international journals have been widely cited, earning them recognition among peers as a leading researcher. Their participation in prestigious conferences and workshops, both as a presenter and a participant, underscores their commitment to continuous learning and sharing knowledge. These recognitions affirm their position as a distinguished professional dedicated to advancing pharmaceutical science and improving healthcare outcomes.

Conclution

The individual’s blend of academic excellence, practical experience, prolific research output, and continuous professional growth makes them a highly suitable candidate for the Best Researcher Award. Their achievements reflect their dedication to advancing pharmaceutical science and their impact on the field.

Publication Top Notes

  1. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency
    • Authors: Nagham H. Kamal, Fatema R. Saber, Abeer Salama, Dalia M. N. Abouhussein, Soha Ismail, Hala M. El-Hefnawy, Meselhy R. Meselhy
    • Year: 2024
    • Citation: Kamal NH, Saber FR, Salama A, Abouhussein DMN, Ismail S, El-Hefnawy HM, Meselhy MR. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency. Future Journal of Pharmaceutical Sciences. 2024 Aug 19. doi:10.1186/s43094-024-00678-2.
  2. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment
    • Authors: Abeer Khattab, Soha Ismail, Areeg M. Abd-Elrazek
    • Year: 2024
    • Citation: Khattab A, Ismail S, Abd-Elrazek AM. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment. AAPS PharmSciTech. 2024 Jun 27. doi:10.1208/s12249-024-02852-4.
  3. Optimization of topical curcumin spanlastics for melanoma treatment
    • Authors: Soha Ismail, Doaa Garhy, Howida K. Ibrahim
    • Year: 2023
    • Citation: Ismail S, Garhy D, Ibrahim HK. Optimization of topical curcumin spanlastics for melanoma treatment. Pharmaceutical Development and Technology. 2023 May 28. doi:10.1080/10837450.2023.2204926.
  4. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation
    • Authors: Marwa H. Shukr, Soha Ismail, Ghada G. El-Hossary, Amany H. El-Shazly
    • Year: 2022
    • Citation: Shukr MH, Ismail S, El-Hossary GG, El-Shazly AH. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation. Journal of Liposome Research. 2022 Oct 2. doi:10.1080/08982104.2022.2025828.
  5. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI
    • Authors: Marwa Farrag Abd El-Aziz, Soha Ismail, Mina Ibrahim Tadros, Mohamed Ahmed Elnabarawi
    • Year: 2020
    • Citation: Abd El-Aziz MF, Ismail S, Tadros MI, Elnabarawi MA. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI. Pharmaceutical Development and Technology. 2020 May 27. doi:10.1080/10837450.2020.1720235.
  6. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity
    • Authors: Marwa H. Shukr, Soha Ismail, Samya Mahmoud Ahmed
    • Year: 2019
    • Citation: Shukr MH, Ismail S, Ahmed SM. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity. Journal of Drug Delivery Science and Technology. 2019 Feb. doi:10.1016/j.jddst.2018.12.001.
  7. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy
    • Authors: Dalia S. Shaker, Soha Ismail, Selwan Hamed, Eman M. El-Shishtawy
    • Year: 2018
    • Citation: Shaker DS, Ismail S, Hamed S, El-Shishtawy EM. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy. Journal of Drug Delivery Science and Technology. 2018 Dec. doi:10.1016/j.jddst.2018.09

 

Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Dr. Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Associate Professor at Quaid-i-Azam University, Pakistan

Dr. Kifayat Ullah Shah is an accomplished academic and researcher in the field of pharmaceutical sciences, currently serving as an Associate Professor at Quaid-e-Azam University in Islamabad since September 2014. He previously held positions as an Assistant Professor at Hamdard University and a Teaching Assistant at Gomal University. Dr. Shah earned his Ph.D. in Pharmaceutics from Gomal University, where he also completed his Bachelor of Pharmacy. His research interests include the formulation and development of pharmaceuticals, controlled drug delivery, and nanotechnology applications in drug delivery. He has authored several publications with significant impact, reflecting his contributions to the field, and has supervised over 35 MPhil and five PhD students. Dr. Shah has received grants for various research projects, showcasing his commitment to advancing pharmaceutical sciences. Additionally, he is actively involved in academic administration and quality assurance within higher education.

Education

Dr. Kifayat Ullah Shah holds an impressive educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (Ph.D.) in Pharmaceutics from Gomal University, Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan, between 2008 and 2014. Prior to that, he obtained a Bachelor of Pharmacy (B.Pharmacy) degree from the same institution, Gomal University, from 2002 to 2006. His early education includes a Pre-Medical F.Sc. from Govt. P.G. College Bannu in 2000-2001 and Matriculation in Science from Govt. High School-02 Bannu in 1998-1999. This strong academic foundation has equipped Dr. Shah with the knowledge and skills necessary to excel in both research and teaching within the field of pharmaceutical sciences.

Professional Experience

Dr. Kifayat Ullah Shah has extensive professional experience in academia and the pharmaceutical industry. He has served as an Associate Professor at Quaid-e-Azam University, Islamabad, since September 2014, where he has contributed to teaching and research in pharmaceutical sciences. Prior to this role, Dr. Shah was an Assistant Professor at Hamdard University from January to August 2014 and worked as a Teaching Assistant at Gomal University for a brief period in late 2011. His early career included experience as a Production Pharmacist at Glitz Pharmaceuticals in Islamabad, where he gained practical insights into pharmaceutical production and formulation. Dr. Shah’s diverse professional background, coupled with his research focus on drug delivery systems and nanotechnology, has positioned him as a prominent figure in his field.

Research Interest

Dr. Kifayat Ullah Shah’s research interests are centered around the formulation and development of pharmaceutical products, with a particular focus on controlled drug delivery systems. His expertise encompasses a variety of advanced techniques, including microencapsulation, nanotechnology, and thermal analysis, which he applies to improve the efficacy and safety of drug formulations. Dr. Shah has conducted significant research on targeted drug delivery mechanisms, exploring innovative methods to enhance therapeutic outcomes for various medical conditions. His work also includes the design, preparation, and evaluation of controlled release polymeric formulations, aiming to investigate drug release patterns and mechanisms. Through his research, Dr. Shah seeks to contribute to the advancement of pharmaceutical sciences and improve patient care through effective drug delivery systems.

Research Skills

Dr. Kifayat Ullah Shah possesses a robust skill set in pharmaceutical research, particularly in the formulation and development of drug delivery systems. His expertise includes advanced techniques such as microencapsulation, controlled drug delivery, and targeted drug delivery, which are essential for optimizing the therapeutic effects of pharmaceuticals. Dr. Shah is proficient in utilizing various analytical instruments, including UV/Visible spectrophotometry, differential scanning calorimetry (DSC), and thermal analysis, to evaluate and characterize pharmaceutical formulations. His research skills also extend to pre-formulation studies and the application of nanotechnology in drug delivery, enabling him to design innovative solutions for complex pharmaceutical challenges. Through his comprehensive knowledge and practical experience, Dr. Shah effectively contributes to the advancement of pharmaceutical sciences and the development of new therapeutic strategies.

Award and Recognition

Dr. Kifayat Ullah Shah has garnered several awards and recognitions throughout his career, highlighting his significant contributions to the field of pharmaceutics. He successfully obtained funding for key research projects, including a grant of 0.5 million PKR from the Higher Education Commission (HEC) of Pakistan for the fabrication, characterization, and in vitro evaluation of finasteride nanoparticles. Additionally, he received a substantial grant of 4.5 million PKR for his project on silica-based nanoparticles as hemostatic agents for controlling internal bleeding. Dr. Shah has also been recognized for his academic excellence, having supervised over 35 MPhil and five PhD students, and for his impactful research publications, which have contributed to advancements in drug delivery systems. His work has earned him respect and acknowledgment in the academic and research communities, reflecting his dedication to enhancing pharmaceutical sciences and improving patient care.

Conclusion

Dr. Kifayat Ullah Shah’s impressive academic credentials, extensive research experience, impactful publications, successful funding acquisitions, and contributions to education and administrative services strongly position him as a deserving candidate for the Research for Best Researcher Award. His ongoing commitment to advancing pharmaceutical sciences through research and mentorship further strengthens his suitability for this recognition.

Publication Top Notes

  • “Non-pharmacological management of hypertension: in the light of current research”
    • Journal: Irish Journal of Medical Science (1971-)
    • Cited by: 180
    • Year: 2019
    • Volume: 188
    • Pages: 437-452
  • “From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)”
    • Journal: Expert Opinion on Drug Delivery
    • Cited by: 148
    • Year: 2017
    • Volume: 14, Issue 11
    • Pages: 1325-1340
  • “Proniosomes derived niosomes: recent advancements in drug delivery and targeting”
    • Journal: Drug Delivery
    • Cited by: 121
    • Year: 2017
    • Volume: 24, Issue 2
    • Pages: 56-69
  • “A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers”
    • Journal: Carbohydrate Polymers
    • Cited by: 106
    • Year: 2020
    • Volume: 250
    • Pages: 116800
  • “Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS)”
    • Journal: Journal of Medicinal Plants Research
    • Cited by: 93
    • Year: 2010
    • Volume: 4, Issue 19
    • Pages: 1987-1990
  • “Polymeric nanogels as versatile nanoplatforms for biomedical applications”
    • Journal: Journal of Nanomaterials
    • Cited by: 81
    • Year: 2019
    • Volume: 2019, Issue 1
    • Pages: 1526186
  • “Hemostatic strategies for uncontrolled bleeding: A comprehensive update”
    • Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials
    • Cited by: 73
    • Year: 2021
    • Volume: 109
  • “Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product”
    • Journal: Journal of Drug Delivery Science and Technology
    • Cited by: 72
    • Year: 2019
    • Volume: 51
    • Pages: 583-590
  • “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis”
    • Journal: International Journal of Clinical Pharmacy
    • Cited by: 56
    • Year: 2021
    • Volume: 43
    • Pages: 486-501
  • “Co-delivery strategies to overcome multidrug resistance in ovarian cancer”
    • Journal: International Journal of Pharmaceutics
    • Cited by: 47
    • Year: 2017
    • Volume: 533, Issue 1
    • Pages: 111-124
  • “Regulating drug release behavior and kinetics from matrix tablets based on fine particle‐sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation”
    • Journal: The Scientific World Journal
    • Cited by: 46
    • Year: 2012
    • Volume: 2012, Issue 1
    • Pages: 842348